leisure time -WSS

leisure time

author：hotspot 2025-09-06 04:14:11 - browse：13328

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Hospitals owned by private equity see complications spike 25%

Wikipedia

WSS

Pfizer's Covid pill remains 89% effective in final analysis, company says

Bacterial infection may be ‘key event’ in endometriosis, study says

Grail is spending more than ever lobbying Congress

Brain 'hot spot' may explain why African Americans feel greater pain

Carvykti CAR

Hospitals owned by private equity see complications spike 25%

explore

leisure time

focus

In Memoriam: Notable people who died in 2023

Can food be medicine? And other questions about a new push

Jerome Adams on the need for new antivirals for Covid

Why is France rioting? What to know about the fatal police shooting of Nahel M

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: The latest on Moderna, Apellis, and Merck

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

In Memoriam: Notable people who died in 2023

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

hotspot

Listen: Biogen's messy board & Laronde's data problem

7 people shot in DC, police say

What STAT readers think about the FDA and patient advocacy

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Three trends to watch in biotech in 2024

Grail is spending more than ever lobbying Congress

Wikipedia

hotspot

focus

leisure time